Qifeng Ding

582 total citations
22 papers, 386 citations indexed

About

Qifeng Ding is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Qifeng Ding has authored 22 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Qifeng Ding's work include Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Qifeng Ding is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Qifeng Ding collaborates with scholars based in China. Qifeng Ding's co-authors include Yongbing Chen, Zhonghua Xu, Fuquan Zhang, Kanqiu Jiang, Weihua Xu, Mingjing Shen, Donglai Chen, Chang Chen, Xiao‐Fan Wang and Yiming Mao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Surgical Oncology.

In The Last Decade

Qifeng Ding

21 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qifeng Ding China	10	169	149	130	86	57	22	386
Xianjing Chu China	7	201 1.2×	100 0.7×	127 1.0×	61 0.7×	87 1.5×	12	399
Tomás G. Lyons United States	10	219 1.3×	106 0.7×	219 1.7×	96 1.1×	60 1.1×	18	442
Stéphane Thibault United States	10	248 1.5×	160 1.1×	168 1.3×	116 1.3×	55 1.0×	16	462
Laurène Froment Switzerland	9	179 1.1×	141 0.9×	182 1.4×	78 0.9×	38 0.7×	14	407
Clelia Donisi Italy	7	225 1.3×	102 0.7×	152 1.2×	102 1.2×	71 1.2×	28	395
Elena Vagia United States	9	256 1.5×	125 0.8×	226 1.7×	153 1.8×	82 1.4×	25	493
Nicole Liscia Italy	7	226 1.3×	112 0.8×	131 1.0×	104 1.2×	73 1.3×	29	374
Weiying Li China	11	126 0.7×	97 0.7×	143 1.1×	106 1.2×	37 0.6×	29	363
Brigida Stanzione Italy	9	218 1.3×	150 1.0×	163 1.3×	132 1.5×	22 0.4×	24	411
Hongge Liang China	10	176 1.0×	174 1.2×	146 1.1×	57 0.7×	41 0.7×	26	369

Countries citing papers authored by Qifeng Ding

Since Specialization

Citations

This map shows the geographic impact of Qifeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Ding more than expected).

Fields of papers citing papers by Qifeng Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Ding. The network helps show where Qifeng Ding may publish in the future.

Co-authorship network of co-authors of Qifeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Ding. A scholar is included among the top collaborators of Qifeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Ding. Qifeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Donglai, Yue Li, Shanshan Shen, et al.. (2025). Which descriptor should spread through air spaces (STAS) be incorporated into? T descriptor versus residual tumor classification. The Journal of Pathology Clinical Research. 11(4). e70039–e70039.

Shen, Yu‐Mei, et al.. (2024). Temporal control in shell–core structured nanofilm for tracheal cartilage regeneration: synergistic optimization of anti-inflammation and chondrogenesis. Regenerative Biomaterials. 11. rbae040–rbae040. 7 indexed citations

Ding, Qifeng, Donglai Chen, Shanshan Shen, et al.. (2023). Clinical profiles and intraoperative identification of complex glands in stage I lung adenocarcinoma. European Journal of Cardio-Thoracic Surgery. 63(3). 2 indexed citations

Shen, Yu‐Mei, et al.. (2023). GIMAP7 inhibits epithelial‐mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway. Thoracic Cancer. 15(4). 286–298. 1 indexed citations

Xu, Xuejun, Yifeng Gao, Shanzhou Duan, et al.. (2023). Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma. Cancer Medicine. 12(8). 9547–9558. 10 indexed citations

Jiang, Kanqiu, Shasha Liu, Yongbing Chen, et al.. (2023). Characterization of TCF‐1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients. Thoracic Cancer. 14(27). 2745–2753. 3 indexed citations

Chen, Donglai, Yifei Wang, Xi Zhang, et al.. (2021). Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses. Frontiers in Oncology. 11. 581030–581030. 12 indexed citations

Shen, Mingjing, Kanqiu Jiang, Zhonghua Xu, et al.. (2021). Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma. Lung Cancer. 160. 84–91. 7 indexed citations

Chen, Donglai, Yiming Mao, Junmiao Wen, et al.. (2021). Impact of the Extent of Lymph Node Dissection on Precise Staging and Survival in Clinical I–II Pure-Solid Lung Cancer Undergoing Lobectomy. Journal of the National Comprehensive Cancer Network. 19(4). 393–402. 9 indexed citations

10.

Chen, Donglai, Xiao‐Fan Wang, Fuquan Zhang, et al.. (2020). Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study. Therapeutic Advances in Medical Oncology. 12. 3863593187–3863593187. 39 indexed citations

11.

Chen, Donglai, Yiming Mao, Qifeng Ding, et al.. (2020). Prognostic implications of programmed death ligand 1 expression in resected lung adenocarcinoma: a systematic review and meta-analysis. European Journal of Cardio-Thoracic Surgery. 58(5). 888–898. 4 indexed citations

12.

Chen, Donglai, Qifeng Ding, Wei Wang, Chang Chen, & Yongbing Chen. (2020). ASO Author Reflections: Old Song, New Sung—Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification. Annals of Surgical Oncology. 28(4). 2099–2100. 1 indexed citations

13.

Chen, Donglai, Yiming Mao, Junmiao Wen, et al.. (2020). Numbers and Stations: Impact of Examined Lymph Node on Precise Staging and Survival of Radiologically Pure-Solid NSCLC: A Multi-Institutional Study. JTO Clinical and Research Reports. 1(3). 100035–100035. 3 indexed citations

14.

Chen, Donglai, Qifeng Ding, Wei Wang, et al.. (2020). Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II–IIIA Lung Adenocarcinoma. Annals of Surgical Oncology. 28(4). 2088–2098. 9 indexed citations

15.

Ding, Qifeng, Donglai Chen, Wei Wang, & Yongbing Chen. (2020). [Progress in Research on the Cribriform Component in Lung Adenocarcinoma].. SHILAP Revista de lepidopterología. 23(7). 621–625. 3 indexed citations

16.

Shen, Mingjing, Zhonghua Xu, Weihua Xu, et al.. (2019). Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 149–149. 157 indexed citations

17.

Ding, Qifeng, Donglai Chen, Xiao‐Fan Wang, et al.. (2019). Characterization of lung adenocarcinoma with a cribriform component reveals its association with spread through air spaces and poor outcomes. Lung Cancer. 134. 238–244. 21 indexed citations

18.

Zhang, Zengli, Huiqian Wang, Qifeng Ding, et al.. (2018). Establishment of patient-derived tumor spheroids for non-small cell lung cancer. PLoS ONE. 13(3). e0194016–e0194016. 59 indexed citations

19.

Zhang, Zengli, Hongfeng Wang, Qifeng Ding, et al.. (2017). The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB. Biomedicine & Pharmacotherapy. 89. 1055–1060. 16 indexed citations

20.

Ding, Qifeng, et al.. (2005). Comparison of Cost-minimization Analyses between Metformin and Acarbose Combined with Insulin in Treating Type2Diabetes Mellitus. Zhongguo yaofang. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact